Welcome to the ACAAI Clinical Trial Resource page which connects physicians to existing clinical trials in allergy, asthma and immunology led by our pharmaceutical partners. Involvement in clinical trials provides the opportunity to further medical research and improve patient outcomes. While the ACAAI does not endorse these trials; we do encourage clinicians and their patients to partake in this valuable resource. Without these clinical trials, medical advancements would be greatly hindered.
To obtain information on how to become involved in a clinical trial, please browse the trial opportunities below.
The following trials listed are from the ACAAI Corporate Council Benefactor Members. If you are not a participating member, but would like to list your trial, please contact Linda Cullison at lindacullison@acaai.org.
Clinical Trials
R668-ABPA-1923 Liberty ABPA AIRED
Regeneron Pharmaceuticals
Phase 3, global, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate efficacy and safety of dupilumab in patients with Allergic Bronchopulmonary Aspergillosis (ABPA).
Eligible patients – see Study information.
